Outcome of patients with high-risk AML and MDS after reduced-intensity conditioning stem cell transplantation

被引：0
|
作者：
Uzunov, M. [1 ]
Wittnebel, S. [2 ]
Boccaccio, C. [2 ]
Bourhis, J. H. [2 ]
机构：
[1] Hop La Pitie Salpetriere, Paris, France
[2] Inst Gustave Roussy, Villejuif, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation after chemotherapy and dose reduced-intensity conditioning for high-risk AML and MDS
    Schleuning, M
    Schmid, C
    Ledderose, G
    Tischer, J
    Weisser, M
    Humann, M
    Kolb, HJ
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S29 - S30
  • [2] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS AFTER FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION
    Michallet, M.
    Detrait, M.
    Chevalier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Labussiere, H.
    Ducastelle, S.
    Fatoum, J.
    Barraco, F.
    Chelghoum, Y.
    Mohty, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 265 - 266
  • [3] REDUCED INTENSITY CONDITIONING STEM CELL TRANSPLANTATION FOR HIGH RISK AML AND MDS - OUTCOME OF PATIENTS IN A SINGLE CENTER
    Uzunov, M.
    Wittnebel, S.
    Boccaccio, C.
    Bourhis, J. H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 134 - 134
  • [4] Outcome of high-risk and refractory AML/MDS patients receiving FLAMSA sequential chemotherapy regimen followed by reduced-intensity conditioning and allogeneic haematopoeitic stem cell transplantation
    Detrait, M.
    Chevalier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Mohty, M.
    Michallet, M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S95 - S96
  • [5] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    Oran, B.
    Giralt, S.
    Couriel, D.
    Hosing, C.
    Shpall, E. J.
    de Meis, E.
    Khouri, I. F.
    Qazilbash, M.
    Anderlini, P.
    Kebriaei, P.
    Popat, U.
    Carrasco-Yalan, A.
    Champlin, R. E.
    de Lima, M.
    [J]. LEUKEMIA, 2007, 21 (12) : 2540 - 2544
  • [6] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    B Oran
    S Giralt
    D Couriel
    C Hosing
    E J Shpall
    E de Meis
    I F Khouri
    M Qazilbash
    P Anderlini
    P Kebriaei
    U Popat
    A Carrasco-Yalan
    R E Champlin
    M de Lima
    [J]. Leukemia, 2007, 21 : 2540 - 2544
  • [7] Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
    Garcia, Jacqueline S.
    Kim, Haesook T.
    Murdock, H. Moses
    Ansuinelli, Michela
    Brock, Jennifer
    Cutler, Corey S.
    Gooptu, Mahasweta
    Ho, Vincent T.
    Koreth, John
    Nikiforow, Sarah
    Romee, Rizwan
    Shapiro, Roman
    Deangelo, Daniel J.
    Stone, Richard M.
    Bat-Erdene, Denbaa
    Ryan, Jeremy
    Contreras, Manuel E.
    Fell, Geoffrey
    Letai, Anthony
    Ritz, Jerome
    Lindsley, R. Coleman
    Soiffer, Robert J.
    Antin, Joseph H.
    [J]. BLOOD ADVANCES, 2024, 8 (04) : 978 - 990
  • [8] Reduced-intensity stem cell transplantation for high-risk thalassaemia major patients
    Sarhan, M
    Nseirat, T
    Jarrar, M
    Salman, H
    Milhem, M
    Abdel-Rahman, F
    Asfour, N
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S197 - S197
  • [9] Reduced-intensity conditioning allogeneic stem cell transplantation for high-risk neuroblastoma: French experience
    Paillard, C.
    Lutz, P.
    Tchirkov, A.
    Cojean, N.
    David, A.
    Dore, E.
    Isfan, F.
    Merlin, E.
    Marabelle, A.
    Rousseau, R.
    Demeocq, F.
    Kanold, J.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S154 - S154
  • [10] Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    M Steiner
    S Matthes-Martin
    A Attarbaschi
    M Minkov
    N Grois
    E Unger
    W Holter
    J Vormoor
    A Wawer
    M Ouachee
    W Woessmann
    H Gadner
    [J]. Bone Marrow Transplantation, 2005, 36 : 215 - 225
12345